Archives
|
Entry
|
Blogger
|
Date
▴
|
Location
|
|
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity
|
Luke Timmerman |
12/17/08 |
Seattle
|
|
Scout Medical: The Device Incubator That Batted 3-For-3
|
Luke Timmerman |
12/01/08 |
Seattle
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
Boston
|
|
Accelerator Startup, GPC-Rx, Uses Computers to Make Drugs Without Side Effects
|
Luke Timmerman |
11/21/08 |
Seattle
|
|
Radius Adds $15M to Series C
|
Ryan McBride |
11/20/08 |
Boston
|
|
Radius Health, Inc. Receives $15,000,000 Series C Round
|
VentureDeal |
11/20/08 |
Boston
|
|
Ceregene Awaits Parkinson’s Trial Results, In a Key Test for Gene Therapy
|
Luke Timmerman |
10/31/08 |
San Diego
|
|
Allozyne, Developer of Multiple Sclerosis Drug in Fewer Shots, Poised to Enter Clinical Trials
|
Luke Timmerman |
10/16/08 |
Seattle
|
|
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/08/08 |
Boston
|
|
MPM Capital, World’s Biggest Healthcare VC Fund, Balances Startups With Stocks
|
Luke Timmerman |
10/07/08 |
Boston
|
|
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/01/08 |
Boston
|
|
Leroy Hood’s Latest Big Idea: Integrated Diagnostics, a Startup that Will Spot Tiny Cancers in Blood
|
Luke Timmerman |
09/26/08 |
Seattle
|
|
With Backing From MPM and Kleiner Perkins, EpiZyme Aims to Turn Genes On and Off
|
Luke Timmerman |
09/26/08 |
Boston
|
|
Archus Orthopedics Is Doing for the Spine What Doctors Do for the Knees, Hips
|
Luke Timmerman |
09/23/08 |
Seattle
|
|
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections
|
Luke Timmerman |
08/28/08 |
Seattle
|
|
An Accelerator, By Any Other Name…Does Not Smell as Sweet
|
Luke Timmerman |
08/11/08 |
Seattle
|
|
Genzyme Pursues Multiple Sclerosis Market, Biogen Reports Progress in Same, BG Medicine Swallows $40 Million Cash Bolus, & More Life Sciences News
|
Rebecca Zacks |
07/23/08 |
Boston
|
|
Yet Another $1 Billion for Evergreen Solar, Alnylam and Novartis Extend Alliance, & More Deals
|
Rebecca Zacks |
07/21/08 |
Boston
|
|
Peptimmune Picks Up $8.9M
|
Rebecca Zacks |
07/17/08 |
Boston
|
|
Patent Reform Blocked, Epix Deal Expanded, Repligen Suit Settled, & More Life Sciences News
|
Rebecca Zacks |
04/09/08 |
Boston
|
|
EMC Tangos with Conchango, MIT Media Lab Goes to the Bank, GT Solar Makes European Inroads, & More Deals News
|
Rebecca Zacks |
04/07/08 |
Boston
|
|
Alinea Pharmaceuticals Inc. Receives $2,000,000 New Financing Round
|
VentureDeal |
03/31/08 |
Boston
|
|
Radius Health, Inc. Obtains $28,300,000 New Financing
|
VentureDeal |
03/31/08 |
Boston
|
|
ISB Accelerator Secures $200,100 New Round
|
VentureDeal |
03/31/08 |
Seattle
|
|
Clarus Ventures Raises $660 Million Life Sciences Fund
|
Robert Buderi |
02/25/08 |
Boston
|
|
MIT Teams With Italian Energy Giant, Elixir Postpones Its IPO, Biogen Idec Will Buy or Be Bought, & More
|
Rebecca Zacks |
01/23/08 |
Boston
|
|
PeptImmune Peps Up with $8 Million Financing
|
Robert Buderi |
01/18/08 |
Boston
|
|
Peptimmune, Inc. Garners $8,200,000 Series D Financing Round
|
VentureDeal |
01/17/08 |
Boston
|
|
Primera Primed with $21 Million Financing Round
|
Robert Buderi |
01/09/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
